Live: Coronavirus Market Crash Coverage

The Motley Fool’s live guide on what investors should do during the stock market crash and the COVID-19 pandemic.

Bear markets are a fact of our investing lives, but they’re still shocking each time they occur. We’ve created this page for all investors seeking advice on what they should be doing in this turbulent period. Our most important content can be found in the Editors' Picks section, answering questions about what to buy right now, how much cash to keep on the sidelines, and what stocks could be the biggest winners once this is all behind us.

And we do believe this will all end up behind us, because we view investing as a long-term endeavor. Borrowing from Warren Buffett: "We have no idea -- and never have had -- whether the market is going to go up, down, or sideways in the near- or intermediate-term future." However, we firmly believe investors will be rewarded over the long term.

We suggest bookmarking this page as we will update our Editors' Picks periodically -- the Recent Articles section is a live feed of our latest thinking. Finally, we understand that many people are seeking epidemiological information on COVID-19. For that we strictly suggest visiting the information pages set up by the CDC and WHO.

For members of The Motley Fool's investing services, you can access all our Coronavirus market coverage at after logging in.

Recent articles

Edge computing circuit circle on blue cube background

Is Fastly Stock a Buy?

Should you buy one of 2020's biggest gainers, or take your money and run?

Airline-Hawaiian Holdings-HA-Airbus A330

Hawaiian Airlines Tries to Get Back to Business

New rules that will allow tourists to avoid a 14-day mandatory quarantine should bolster demand for travel to Hawaii next month.


3 Top Dividend Stocks to Buy Right Now

Sometimes, simple things like reliable income just make more sense.


Is Clorox Stock a Buy?

How Clorox is navigating through COVID-19.

Woman in apron at table holding pen over document and typing on calculator_GettyImages-1125917207

What to Do if You Can't Use Your Entire PPP Loan

Many small businesses have depleted their PPP loans. But what if you're in the opposite boat and can't use yours in full?

Airline-American Airlines plane AAL

American Airlines Abandons Unprofitable International Routes

The airline giant plans to operate a much smaller long-haul international network next summer than it did pre-coronavirus.

US Capitol Building

If There's a Second Stimulus Check, Here's When You'll Most Likely Get Your Money

There's no guarantee more money will come, but if it does, this is probably when you'll receive your payments.


Here's What to Look for When Netflix Reports Earnings

The company is expecting to report adding millions of subscribers in the quarter.

Injecting COVID-19 vaccine into globe

3 Reasons You Shouldn't Get Your Hopes Too High About COVID-19 Vaccines

It won't be a slam dunk for vaccines to turn the tide against the pandemic.

ino stock inovio stock covid-19 vaccine coronavirus vaccine

Why Inovio Stock Soared 83% in June

Shares of the COVID-19 vaccine developer have been on fire in 2020. ,

Novavax scientist

Novavax Awarded $1.6 Billion From Operation Warp Speed to Fund COVID-19 Vaccine Program

The funds will support the rapid development and mass production of the biotech's coronavirus vaccine candidate, NVX-CoV2373.


Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics

Shares of these two coronavirus stocks are soaring -- which one is the better buy?

US Capitol Building

Group Excluded From First Stimulus Checks Now Getting Bipartisan Support for Inclusion

Will families with mixed immigrant status who were excluded finally get their coronavirus relief payments?


Moderna’s COVID-19 Trial Delayed: Should Investors Worry?

Could this spell the end of Moderna’s dazzling run on the stock market this year?

COVID-19 vaccine

Better Coronavirus Stock: VBI Vaccines or Vaxart?

There's more to these small biotechs than just their coronavirus vaccine programs.

Doctor holding COVID-19 vaccine with thumb up

Does Pfizer's COVID-19 Vaccine Make the Big Pharma Stock a Buy?

The answer comes with an asterisk.

money in an envelope

The President Promised Your Next Stimulus Check Would Be Generous -- But Don't Count on It

A bigger second payment may not be in the cards.

Bed Bath & Beyond gift card

Earnings Preview: How Bad Was Bed Bath & Beyond's First Quarter?

The new management team faces an uphill battle to revive the ailing home furnishings retailer.

Industrials-Autos-General Motors Cadillac XT4-GM

Q2 Sales Plummet at GM and Ford as Coronavirus Takes a Toll

The COVID-19 pandemic significantly reduced supply and demand last quarter.

Man wearing mask that looks like $100 bill

Is This Under-the-Radar Stock a Better Coronavirus Play Than Moderna?

This company will make money from Moderna's COVID-19 vaccine even if Moderna doesn't.